Canterbury, October 29: Researchers during a recent study identified a potential new treatment that suppresses the replication of SARS-CoV-2, the virus that causes Covid-19.
In order to multiply, all viruses, including coronaviruses, infect cells and reprogramme them to produce novel viruses. The study 'Targeting the pentose phosphate pathway for SARS-CoV-2 therapy' has been published by the scientific journal Metabolite.
Also Read | 1 in 7 Indians Suffered from Mental Disorders in 2017, Anxiety and Depression Top the List: Study.
The research revealed that cells infected with SARS-CoV-2 can only produce novel coronaviruses when their metabolic pentose phosphate pathway is activated.
When applying the drug benfooxythiamine, an inhibitor of this pathway, SARS-CoV-2 replication was suppressed and infected cells did not produce coronaviruses.
The research from the University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, found the drug also increased the antiviral activity of '2-deoxy-D-glucose'; a drug which modifies the host cell's metabolism to reduce virus multiplication.
This shows that pentose phosphate pathway inhibitors like benfooxythiamine are a potential new treatment option for COVID-19, both on their own and in combination with other treatments.
Additionally, Benfooxythiamin's antiviral mechanism differs from that of other COVID-19 drugs such as remdesivir and molnupiravir. Therefore, viruses resistant to these may be sensitive to benfooxythiamin.
Professor Martin Michaelis, University of Kent, said, "This is a breakthrough in the research of COVID-19 treatment. Since resistance development is a big problem in the treatment of viral diseases, having therapies that use different targets is very important and provides further hope for developing the most effective treatments for COVID-19."
"Targeting virus-induced changes in the host cell metabolism is an attractive way to interfere specifically with the virus replication process," added Professor Jindrich Cinatl from Goethe-University Frankfurt
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)













Quickly


